Cargando…
UDP-glucose dehydrogenase (UGDH) in clinical oncology and cancer biology
UDP-glucose-6-dehydrogenase (UGDH) is a cytosolic, hexameric enzyme that converts UDP-glucose to UDP-glucuronic acid (UDP-GlcUA), a key reaction in hormone and xenobiotic metabolism and in the production of extracellular matrix precursors. In this review, we classify UGDH as a molecular indicator of...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10538703/ https://www.ncbi.nlm.nih.gov/pubmed/37769033 http://dx.doi.org/10.18632/oncotarget.28514 |
_version_ | 1785113356502302720 |
---|---|
author | Price, Meghan J. Nguyen, Annee D. Byemerwa, Jovita K. Flowers, Jasmine Baëta, César D. Goodwin, C. Rory |
author_facet | Price, Meghan J. Nguyen, Annee D. Byemerwa, Jovita K. Flowers, Jasmine Baëta, César D. Goodwin, C. Rory |
author_sort | Price, Meghan J. |
collection | PubMed |
description | UDP-glucose-6-dehydrogenase (UGDH) is a cytosolic, hexameric enzyme that converts UDP-glucose to UDP-glucuronic acid (UDP-GlcUA), a key reaction in hormone and xenobiotic metabolism and in the production of extracellular matrix precursors. In this review, we classify UGDH as a molecular indicator of tumor progression in multiple cancer types, describe its involvement in key canonical cancer signaling pathways, and identify methods to inhibit UGDH, its substrates, and its downstream products. As such, we position UGDH as an enzyme to be exploited as a potential prognostication marker in oncology and a therapeutic target in cancer biology. |
format | Online Article Text |
id | pubmed-10538703 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-105387032023-09-29 UDP-glucose dehydrogenase (UGDH) in clinical oncology and cancer biology Price, Meghan J. Nguyen, Annee D. Byemerwa, Jovita K. Flowers, Jasmine Baëta, César D. Goodwin, C. Rory Oncotarget Review UDP-glucose-6-dehydrogenase (UGDH) is a cytosolic, hexameric enzyme that converts UDP-glucose to UDP-glucuronic acid (UDP-GlcUA), a key reaction in hormone and xenobiotic metabolism and in the production of extracellular matrix precursors. In this review, we classify UGDH as a molecular indicator of tumor progression in multiple cancer types, describe its involvement in key canonical cancer signaling pathways, and identify methods to inhibit UGDH, its substrates, and its downstream products. As such, we position UGDH as an enzyme to be exploited as a potential prognostication marker in oncology and a therapeutic target in cancer biology. Impact Journals LLC 2023-09-28 /pmc/articles/PMC10538703/ /pubmed/37769033 http://dx.doi.org/10.18632/oncotarget.28514 Text en Copyright: © 2023 Price et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Review Price, Meghan J. Nguyen, Annee D. Byemerwa, Jovita K. Flowers, Jasmine Baëta, César D. Goodwin, C. Rory UDP-glucose dehydrogenase (UGDH) in clinical oncology and cancer biology |
title | UDP-glucose dehydrogenase (UGDH) in clinical oncology and cancer biology |
title_full | UDP-glucose dehydrogenase (UGDH) in clinical oncology and cancer biology |
title_fullStr | UDP-glucose dehydrogenase (UGDH) in clinical oncology and cancer biology |
title_full_unstemmed | UDP-glucose dehydrogenase (UGDH) in clinical oncology and cancer biology |
title_short | UDP-glucose dehydrogenase (UGDH) in clinical oncology and cancer biology |
title_sort | udp-glucose dehydrogenase (ugdh) in clinical oncology and cancer biology |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10538703/ https://www.ncbi.nlm.nih.gov/pubmed/37769033 http://dx.doi.org/10.18632/oncotarget.28514 |
work_keys_str_mv | AT pricemeghanj udpglucosedehydrogenaseugdhinclinicaloncologyandcancerbiology AT nguyenanneed udpglucosedehydrogenaseugdhinclinicaloncologyandcancerbiology AT byemerwajovitak udpglucosedehydrogenaseugdhinclinicaloncologyandcancerbiology AT flowersjasmine udpglucosedehydrogenaseugdhinclinicaloncologyandcancerbiology AT baetacesard udpglucosedehydrogenaseugdhinclinicaloncologyandcancerbiology AT goodwincrory udpglucosedehydrogenaseugdhinclinicaloncologyandcancerbiology |